Table 2.
Predictors of study non‐attendance among TGW enrolled in PrEParadas study, Rio de Janeiro, Brazil, 2017–2019
| Unadjusted | Adjusted | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p‐value | aOR | 95% CI | p‐value | |
| Study visit | ||||||
| Week 4 | 1 | 1 | ||||
| Week 12 | 1.00 | 0.36, 2.80 | >0.9 | 1.04 | 0.38, 2.87 | 0.94 |
| Week 24 | 2.52 | 0.96, 6.63 | 0.06 | 2.57 | 0.99, 6.63 | 0.05 |
| Week 36 | 2.77 | 1.06, 7.28 | 0.04 | 2.83 | 1.10, 7.28 | 0.03 |
| Week 48 | 2.28 | 0.86, 6.02 | 0.10 | 2.35 | 0.91, 6.09 | 0.08 |
| Age (years) a | ||||||
| 18–24 | 10.6 | 2.36, 47.9 | 0.0021 | 8.76 | 2.09, 36.7 | 0.0030 |
| 25–34 | 9.01 | 2.18, 37.2 | 0.0024 | 6.79 | 1.72, 26.8 | 0.0063 |
| 35+ | 1 | 1 | ||||
| Schooling (years) a | ||||||
| 0–7 | 1.77 | 0.43, 7.22 | 0.40 | |||
| 8+ | 1 | |||||
| Race/colour a , b | ||||||
| Black | 1.47 | 0.31, 6.93 | 0.60 | |||
| Mixed/Pardo | 0.62 | 0.15, 2.62 | 0.50 | |||
| White | 1 | |||||
| Housing a | ||||||
| Own/rent | 1 | |||||
| Other c | 2.33 | 0.63, 8.55 | 0.20 | |||
| Perceived financial situation a | ||||||
| Comfortable | 1 | |||||
| Less than comfortable | 1.19 | 0.35, 4.10 | 0.80 | |||
| Main sexual partner a , d (ref: No) | 3.38 | 0.98, 11.6 | 0.05 | 2.32 | 0.77, 6.94 | 0.13 |
| Sex work a (ref: No) | 1.89 | 0.57, 6.26 | 0.30 | |||
| Condomless receptive anal sex a (ref: No) | 1.78 | 0.51, 6.20 | 0.40 | |||
| Binge drinking a (ref: No) | 2.24 | 0.66, 7.58 | 0.20 | |||
| Stimulant use a (ref: No) | 7.17 | 1.73, 29.7 | 0.0066 | 4.99 | 1.37, 18.1 | 0.02 |
| Physical violence (ref: No) | 0.50 | 0.14, 1.88 | 0.30 | |||
| Any FHT use a (ref: No) | 0.60 | 0.17, 2.09 | 0.40 | |||
| Positive screening depression a , e (ref: No) | 0.81 | 0.19, 3.38 | 0.80 | |||
| STI diagnosis a , f | 2.78 | 0.74, 10.4 | 0.13 | |||
| Self‐perceived HIV risk a | ||||||
| <75% | 1 | |||||
| 75%+ | 0.32 | 0.03, 3.21 | 0.30 | |||
| Received text message | 0.62 | 0.18, 2.19 | 0.50 | |||
Abbreviations: aOR, adjusted OR; CI, confidence interval; FHT, feminizing hormone therapy; HIV, human immunodeficiency virus; OR, odds ratio; STI, sexually transmitted infection; TGW, transgender women.
a
Baseline data.
b
Asian and Indigenous participants excluded.
c
Includes people living in house/apartment that belongs to the family, guest house, shelter or institution, non‐governmental organization, at work, living as a favour and homeless.
d
Someone that the participant considers as her primary sexual partner and feels committed to.
e
3+ score in the Patient Health Questionnaire‐2.
f
Syphilis, rectal Chlamydia or Gonorrhoea.